General practitioner · Hasselt · BE · Founded 2018 · Accounts through 2025 · Updated Jul 27, 2026
No public value estimate is available for this company yet. Review the registered details, express interest or claim the profile as the owner.
Is this your company? Claim and manage this profile
DR. VANDERSMISSEN LIEVE has public filings, but the EBITDA/revenue relationship looks proxy-based or incomplete. Upswitch withholds the public range until clean turnover and normalised EBITDA are verified.
Create a free account to add verified turnover, normalised EBITDA, debt and one-offs for DR. VANDERSMISSEN LIEVE in a private workspace.
We keep this public page conservative, so weak filings never become a false price.The page can still show filed facts, but the automatic public range is blocked when those facts would make the multiple misleading.
DR. VANDERSMISSEN LIEVE, a general practitioner, is registered at an address in Hasselt, Belgium. The company was founded in 2018, incorporated as a Besloten Vennootschap.
DR. VANDERSMISSEN LIEVE is listed in Belgian Crossroads Bank for Enterprises (KBO) under registry number 0687608848 and VAT number BE0687608848. This profile consolidates KBO registry, official annual accounts into one indexable company dossier.
Within the Belgian NACE 86.21 cluster, public-record data is filed annually via the national company registry.
Across the 2024-2025 window the gross-margin line has more than doubled, moving from €125,088 to €199,439. EBITDA for 2025 comes in at €198,977. Because this line is gross margin from an abbreviated filing, not reported turnover, it is treated as public context rather than an automatic valuation base.
The most recent annual filing covers 2025 (period end 2025-12-31).
The data on this page is a public, point-in-time view of DR. VANDERSMISSEN LIEVE's regulator-filed footprint, built to support sellability context and acquisition research without overstating the public valuation evidence.
Register your interest privately. Upswitch reviews every request and keeps it queued until a safe, verified owner contact route is available.
This is an estimate, not an asking price. It is based on dated public sources and is not an owner forecast, offer, investment advice, or confirmation that the company is for sale.
Request verified control to add current figures, improve the profile and manage what happens next. We verify ownership before granting access.
Claim this companyPublic regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €199,439 | €198,977 | €546,178 | €523,071 | - |
| 202431 Dec 2024 | €125,088 | €124,450 | €467,774 | €455,561 | - |
DR. VANDERSMISSEN LIEVE was founded in 2018 and is registered with Belgian Crossroads Bank for Enterprises (KBO), incorporated as a Besloten Vennootschap.
DR. VANDERSMISSEN LIEVE is registered under NACE 86.21. That places the business within the Belgian cluster for this activity.
According to the company registry, DR. VANDERSMISSEN LIEVE is based in Hasselt, BE.
The most recently filed annual accounts cover fiscal year 2025 (period end 2025-12-31), publicly available via Belgian Crossroads Bank for Enterprises (KBO).
This page shows official or licensed public company facts and valuation-readiness context for DR. VANDERSMISSEN LIEVE; it does not show an automated public valuation range. The available facts may be incomplete or inaccurate and must not be relied upon for any transaction; a precise valuation needs owner- or advisor-supplied data.
Company identity and public facts are reused from the official or licensed source named on this page, with its filing or update date. Upswitch estimates remain distinct from source facts and do not imply endorsement by the registry. Natural-person enterprises are excluded from public valuation pages, and public registry personal data is not used for direct marketing.
Connected to this company and want something corrected? Request a correction or removal · Privacy policy · Terms & conditions · Data sources & evidence
Indicative public valuation range based on financial year 2025. This historical record does not yet contain an immutable calculation snapshot, so no sector range is reconstructed after the fact. Not a transaction value, asking price or fairness opinion.
